Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation

Julie M. Vose, Thomas M. Habermann, Myron S. Czuczman, Pier Luigi Zinzani, Craig B. Reeder, Joseph Tuscano, Izidore S. Lossos, Ju Li, Dennis Pietronigro, Thomas E. Witzig

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences